Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

R-483 does not interact with drugs metabolized by cytochrome P450 isoenzymes

March 7, 2005

Ferring signs infertility agreement with Metris Therapeutics for vorozole

March 7, 2005

NBI-56418 shows promise in the treatment of endometriosis

March 7, 2005

Long-acting insulin analog Albulin effective in diabetic mice

March 7, 2005

Phase II data support the use of SPP-301 in diabetic nephropathy

March 4, 2005

Tercica submits NDA for Increlex

March 4, 2005

New cannabinoid CB1 receptor modulators prepared and tested at AstraZeneca

March 3, 2005

Exubera NDA accepted for filing

March 3, 2005

Approvable letter for Glumetza

March 2, 2005

NeuroSearch researchers disclose new chloride channel blocking agents

March 1, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...